Related Experiment Video
Updated: Oct 18, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Diagnosis and Acute Management of COVID-19 and Multisystem Inflammatory Syndrome in Children
Teresa B Kortz, Emilia Connolly, C Lee Cohen
1Resident in Pediatrics, Department of Pediatrics, Weill Cornell Medicine, New York City, NY.
Insights
Most children with COVID-19 are asymptomatic, but 5% develop severe disease. Rapid identification and treatment are crucial for critically ill pediatric patients with respiratory failure or shock.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) primarily affects adults, but children can also be infected.
- While most pediatric COVID-19 cases are mild, a subset progresses to severe or critical illness.
- Severe COVID-19 in children can manifest as respiratory failure, septic shock, and multisystem inflammatory syndrome.
Purpose of the Study:
- To review the epidemiology of SARS-CoV-2 in children.
- To outline clinical assessment strategies for identifying high-risk pediatric patients with severe COVID-19.
- To provide guidance on emergency department management of severe COVID-19 in children.
Main Methods:
- Review of current epidemiology of SARS-CoV-2 in pediatric populations.
- Summary of clinical assessment findings for severe COVID-19.
- Overview of emergency department management protocols based on disease severity.
Main Results:
- The epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children is presented.
- Key clinical assessment findings, including high-risk patient identification and severe disease manifestations, are summarized.
- Management strategies for COVID-19 in the emergency department setting are discussed.
Conclusions:
- Effective management of severe COVID-19 in children requires prompt recognition and intervention.
- Pediatricians and emergency care providers need updated information on SARS-CoV-2 in children.
- Tailored emergency care based on clinical severity is essential for critically ill pediatric patients.
Abstract:
Most children with coronavirus disease 2019 (COVID-19) infection are asymptomatic or have mild disease. About 5% of infected children will develop severe or critical disease. Rapid identification and treatment are essential for children who are critically ill with signs and symptoms of respiratory failure, septic shock, and multisystem inflammatory syndrome in children. This article is intended for pediatricians, pediatric emergency physicians, and individuals involved in the emergency care of children. It reviews the current epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children, summarizes key aspects of clinical assessment including identification of high-risk patients and manifestations of severe disease, and provides an overview of COVID-19 management in the emergency department based on clinical severity.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Tonsillitis II: Management
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Pyelonephritis II: Diagnostic Studies and Management

